{"id":"peg-ascorbate-2l","safety":{"commonSideEffects":[{"rate":null,"effect":"Gastrointestinal disturbances"},{"rate":null,"effect":"Infusion-related reactions"},{"rate":null,"effect":"Hyperglycemia"}]},"_chembl":{"chemblId":"CHEMBL591665","moleculeType":"Small molecule","molecularWeight":"198.11"},"_dailymed":null,"mechanism":{"_ai_source":"anthropic-haiku","explanation":"By conjugating ascorbic acid (vitamin C) to polyethylene glycol, the drug aims to enhance pharmacokinetic properties, improve cellular uptake, and maintain higher circulating levels of ascorbate. This may enable ascorbate to exert pro-oxidant effects at high concentrations in cancer cells while providing antioxidant protection to normal tissues, potentially enhancing therapeutic efficacy in oncology applications.","oneSentence":"PEG-ascorbate 2L is a polyethylene glycol-conjugated form of vitamin C designed to improve systemic delivery and bioavailability of ascorbate for antioxidant and potential anti-cancer effects.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:26:05.880Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Cancer (specific indication under investigation in phase 3 trial)"}]},"trialDetails":[{"nctId":"NCT07320989","phase":"NA","title":"Impact of Chewing Gum on Bowel Preparation in Patients Undergoing Colonoscopy","status":"NOT_YET_RECRUITING","sponsor":"University of Maryland, Baltimore","startDate":"2025-12-21","conditions":"Colon Cancer Screening","enrollment":100},{"nctId":"NCT04759885","phase":"PHASE2, PHASE3","title":"Efficacy and Safety of mAnnitol in Bowel Preparation During Elective Colonoscopy and Comparison With Moviprep®","status":"COMPLETED","sponsor":"NTC srl","startDate":"2020-06-18","conditions":"Elective Colonoscopy","enrollment":886},{"nctId":"NCT05242562","phase":"NA","title":"Effect of Low-volume (1L) vs Intermediate-volume (2L) Bowel Preparation on Cost-effectiveness and Quality of Life","status":"COMPLETED","sponsor":"Radboud University Medical Center","startDate":"2022-05-16","conditions":"Colorectal Cancer, Colonic Polyp","enrollment":509},{"nctId":"NCT04970173","phase":"","title":"1L-PEG-Asc Solution for Bowel Preparation in an \"Open Access\" Colonoscopy Booking System: Evaluation of Adverse Events","status":"COMPLETED","sponsor":"Azienda USL Modena","startDate":"2019-01-01","conditions":"Bowel Preparation","enrollment":5981},{"nctId":"NCT05249335","phase":"PHASE4","title":"Comparison for Efficacy and Safety of Bowel Preparation Between Oral Sulfate Table and 2L-polyethylene Glycol/Ascorbate in Elderly","status":"UNKNOWN","sponsor":"Pharmbio Korea Co., Ltd.","startDate":"2022-02","conditions":"Colonic Disease, Intestinal Disease","enrollment":256},{"nctId":"NCT04708366","phase":"PHASE4","title":"Colon Cleansing Efficacy With 1L vs. 2L vs. 4L-PEG for Colonoscopy Among Inpatients","status":"UNKNOWN","sponsor":"University of Bologna","startDate":"2021-02-01","conditions":"Colon Disease","enrollment":846},{"nctId":"NCT03698474","phase":"PHASE4","title":"Comparison of Different Low Volume Solutions Prior to Colonoscopy","status":"COMPLETED","sponsor":"Tomas Bata Hospital, Czech Republic","startDate":"2018-10-25","conditions":"Colonoscopy","enrollment":612},{"nctId":"NCT02540031","phase":"PHASE3","title":"The Impact of Additional Oral Preparation on the Quality of Bowel Preparation for Colonoscopy","status":"COMPLETED","sponsor":"Kyungpook National University Hospital","startDate":"2015-09","conditions":"Bowel Preparation Quality","enrollment":156},{"nctId":"NCT03520361","phase":"PHASE4","title":"Comparison Between OSS and 2L PEG/Asc for Bowel Preparation of Elderly People","status":"UNKNOWN","sponsor":"KangWon National University Hospital","startDate":"2017-11-02","conditions":"Colonoscopy","enrollment":198},{"nctId":"NCT01745835","phase":"PHASE3","title":"Comparison Between 2L Coolprep® and Combination of 1L Coolprep® and Bisacodyl as Bowel Preparation","status":"COMPLETED","sponsor":"Seoul National University Hospital","startDate":"2013-01-30","conditions":"Healthy Person, Bowel Preparation Before Colonoscopy","enrollment":196},{"nctId":"NCT02297399","phase":"PHASE3","title":"Improvement of Tolerance of Bowel Cleansing Before Colonoscopy in Diabetic Patients","status":"COMPLETED","sponsor":"Parc de Salut Mar","startDate":"2014-12-02","conditions":"Diabetes Mellitus, Colonic Diseases","enrollment":158},{"nctId":"NCT01774175","phase":"","title":"Comparison Between Coolprep and Picolyte for Bowel Cleansing","status":"UNKNOWN","sponsor":"Gachon University Gil Medical Center","startDate":"2013-01","conditions":"Stasis; Colon","enrollment":250},{"nctId":"NCT01509131","phase":"PHASE4","title":"Evaluation of a Mixed Bowel Prep (2L PEG + Bisacodyl) Versus PEG With Ascorbate","status":"COMPLETED","sponsor":"Promefarm S.r.l.","startDate":"2010-03","conditions":"Colonoscopy","enrollment":408},{"nctId":"NCT00427089","phase":"PHASE3","title":"Comparison of 2L NRL994 With NaP Preparation in Colon Cleansing Prior to Colonoscopies for Colon Tumor Screening","status":"COMPLETED","sponsor":"Norgine","startDate":"2004-09","conditions":"Colonoscopy","enrollment":360},{"nctId":"NCT00389233","phase":"PHASE3","title":"A Phase III Trial to Assess the Efficacy, Acceptability and Safety of Moviprep® Versus a 4L PEG+E Standard Solution","status":"COMPLETED","sponsor":"Norgine","startDate":"2002-06","conditions":"Colonoscopy","enrollment":360},{"nctId":"NCT00322062","phase":"PHASE3","title":"MOVIPREP® Versus NaP Pivotal Phase III Study","status":"COMPLETED","sponsor":"Norgine","startDate":"2002-04","conditions":"Colonoscopy","enrollment":340}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":5,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Moviprep®"],"phase":"phase_3","status":"active","brandName":"PEG-ascorbate 2L","genericName":"PEG-ascorbate 2L","companyName":"Parc de Salut Mar","companyId":"parc-de-salut-mar","modality":"Small molecule","firstApprovalDate":"","aiSummary":"PEG-ascorbate 2L is a polyethylene glycol-conjugated form of vitamin C designed to improve systemic delivery and bioavailability of ascorbate for antioxidant and potential anti-cancer effects. Used for Cancer (specific indication under investigation in phase 3 trial).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}